Atlantic Therapeutics Appoints Former Zeltiq CEO As Chairman
Executive Summary
Atlantic Therapeutics has appointed former Zeltiq Aesthetics CEO Gordie Nye as its new chairman to help drive adoption of its CE-marked Innovo device for treating clinical conditions associated with pelvic floor weakness.
You may also be interested in...
Start-Up Spotlight: Atlantic Therapeutics, Stimulating The Stress Incontinence Market With Vaginal Mesh Alternative
While controversy over vaginal mesh implants and the serious complications resulting from these devices eroding inside the patient continue unabated across the globe, one Irish company is looking to capitalize on this opportune time by offering a noninvasive solution to stress urinary incontinence. Atlantic Therapeutics has recently won the backing of European healthcare VCs, raising €15m in a Series A round.
Allergan Pays $2bn-Plus For Zeltiq, Expanding Aesthetics Business
Zeltiq's CoolSculpting body-contouring system will be the third "pillar" in Allergan's aesthetics business, along with its existing facial aesthetics and plastic and regenerative surgery lines, the company says.
Qiagen’s Ambitions: Standing Alone And Strengthening Infectious Disease Portfolio
Qiagen official Antoine Marchal outlines how NeuModx will strengthen its position in the infectious disease space.